Skip to main content
Clinical Trials/ACTRN12617001408370
ACTRN12617001408370
Active, not recruiting
未知

Exercise as a diagnostic and therapeutic tool for the prevention of cardiovascular morbidity in breast cancer survivors - a randomised trial

Baker Heart and Diabetes Institute0 sites103 target enrollmentOctober 5, 2017

Overview

Phase
未知
Intervention
Not specified
Conditions
Breast Cancer
Sponsor
Baker Heart and Diabetes Institute
Enrollment
103
Status
Active, not recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
October 5, 2017
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional
Sex
Female

Investigators

Eligibility Criteria

Inclusion Criteria

  • Women aged 40\-75 years who have been diagnosed with breast cancer and are scheduled to undergo anthracycline\-based chemotherapy will be eligible to participate in the study. All eligible participants must also obtain medical approval from their physician before participating.

Exclusion Criteria

  • Participants will be excluded if they (1\) have known structural heart disease (such as symptomatic ischemic heart disease, significant valvular disease or inherited cardiomyopathies), (2\) have contraindications to the CMR procedure (pacemakers, implanted metallic foreign body or device), (3\) have the presence of any serious contraindication or uncontrolled medical condition that would limit participation in the exercise program, (4\) an inability to complete questionnaires in english language or (5\) significant cognitive impairment.

Outcomes

Primary Outcomes

Not specified

Similar Trials